Protein-containing aqueous liquid formulation
US11738068B2 · kind B2 · utility
0Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2019 |
| Grant date | Aug 29, 2023 |
| Priority date | — |
| Expiry date | Sep 4, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2827
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous preparation containing a protein as an active ingredient which is stable in storage in solution and makes an injection pain reduced is provided. More specifically an aqueous preparation containing a phosphate buffer at a concentration of 1 to 20 mM and a protein as an active ingredient is provided. Further more specifically provided is an aqueous preparation containing a phosphate buffer at a concentration of 1 to 20 mM, human growth hormone as an active ingredient, a poloxamer as a non-ionic surfactant; and phenol as a isotonic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.